Schmidt-Brand succeeds Llewellyn-Davis at Wilex
This article was originally published in Scrip
Wilex CFO Peter Llewellyn-Davis will step down upon expiry on his contract to pursue new professional challenges. He will be succeeded by Dr Jan Schmidt-Brand, currently managing director of Wilex's Heidelberg Pharma GmbH subsidiary, effective 1 September 2012. Mr Llewellyn-Davis will act as an advisor to Wilex and will fully manage and complete the capital measure announced by the company on 3 August 2012.